In this video, Shikha Saxena, MD, attending physician of the division of pulmonary and sleep medicine at the Children's ...

Researchers and doctors are beginning to modernize asthma treatment using innovative therapies. Asthma is a common, chronic, ...

Treatment with twice-yearly depemokimab resulted in a significant reduction in the rate of annualized asthma exacerbations compared with placebo. The Food and Drug Administration (FDA) has approved ...

Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two doses annually. Phase 3 trials demonstrated significant reductions in asthma ...

Dec 12 (Reuters) - The European Medicines Agency has recommended the approval of GSK's (GSK.L), opens new tab add-on drug to treat asthma and a chronic inflammatory sinus condition, the company said ...

Please provide your email address to receive an email when new articles are posted on . The COVID-adjusted annualized asthma exacerbation rate dropped by 46%. Mean cumulative oral corticosteroid dose ...

Please provide your email address to receive an email when new articles are posted on . The annualized exacerbation rate was 3.18 per patient-year before tezepelumab and 1.97 per patient-year after ...

Scientists found that RSV infection early in life can set the stage for childhood asthma, particularly in kids already genetically prone to allergies. The virus appears to skew the developing immune ...

Bananas are a popular and nutritious fruit that can help boost energy, support digestion, and provide essential nutrients like potassium and vitamin B6. Although bananas can fit easily into a balanced ...

Please provide your email address to receive an email when new articles are posted on . Researchers found a significantly higher mean number of asthma exacerbations among patients with heart failure ...

Please provide your email address to receive an email when new articles are posted on . Data came from the FDA Adverse Event Reporting System from 2004 to 2024. Omalizumab had significant associations ...